Northern Trust’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $180K | Hold |
100,170
| – | – | ﹤0.01% | 3970 |
|
|
2025
Q1 | $191K | Buy |
100,170
+15,584
| +18% | +$29.8K | ﹤0.01% | 3958 |
|
|
2024
Q4 | $183K | Buy |
84,586
+39,642
| +88% | +$85.6K | ﹤0.01% | 4018 |
|
|
2024
Q3 | $80K | Hold |
44,944
| – | – | ﹤0.01% | 4108 |
|
|
2024
Q2 | $57.5K | Sell |
44,944
-1,542
| -3% | -$1.97K | ﹤0.01% | 4188 |
|
|
2024
Q1 | $175K | Buy |
46,486
+2,973
| +7% | +$11.2K | ﹤0.01% | 3938 |
|
|
2023
Q4 | $142K | Buy |
43,513
+30,236
| +228% | +$98.7K | ﹤0.01% | 4019 |
|
|
2023
Q3 | $43.5K | Hold |
13,277
| – | – | ﹤0.01% | 4199 |
|
|
2023
Q2 | $59.5K | Hold |
13,277
| – | – | ﹤0.01% | 4175 |
|
|
2023
Q1 | $64K | Buy |
13,277
+731
| +6% | +$3.52K | ﹤0.01% | 4201 |
|
|
2022
Q4 | $39.3K | Hold |
12,546
| – | – | ﹤0.01% | 4341 |
|
|
2022
Q3 | $41K | Buy |
+12,546
| New | +$41K | ﹤0.01% | 4378 |
|